Cholesterol, LDL

"Cholesterol, LDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol.

Descriptor ID	D008078
MeSH Number(s)	D04.210.500.247.808.197.244 D10.532.515.500 D10.570.938.208.275 D12.776.521.550.500
Concept/Terms	Cholesterol, LDL Cholesterol, LDL Low Density Lipoprotein Cholesterol beta-Lipoprotein Cholesterol Cholesterol, beta-Lipoprotein beta Lipoprotein Cholesterol LDL Cholesterol Cholesteryl Linoleate, LDL Cholesteryl Linoleate, LDL LDL Cholesteryl Linoleate

Below are MeSH descriptors whose meaning is more general than "Cholesterol, LDL".

Chemicals and Drugs [D]
Polycyclic Compounds [D04]
Fused-Ring Compounds [D04.210]
Steroids [D04.210.500]
Cholestanes [D04.210.500.247]
Sterols [D04.210.500.247.808]
Cholesterol [D04.210.500.247.808.197]
Cholesterol, LDL [D04.210.500.247.808.197.244]
Lipids [D10]
Lipoproteins [D10.532]
Lipoproteins, LDL [D10.532.515]
Cholesterol, LDL [D10.532.515.500]
Membrane Lipids [D10.570]
Sterols [D10.570.938]
Cholesterol [D10.570.938.208]
Cholesterol, LDL [D10.570.938.208.275]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Lipoproteins [D12.776.521]
Lipoproteins, LDL [D12.776.521.550]
Cholesterol, LDL [D12.776.521.550.500]

Below are MeSH descriptors whose meaning is related to "Cholesterol, LDL".

Below are MeSH descriptors whose meaning is more specific than "Cholesterol, LDL".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cholesterol, LDL" by people in this website by year, and whether "Cholesterol, LDL" was a major or minor topic of these publications.

Bar chart showing 64 publications over 21 distinct years, with a maximum of 7 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	2	2
2003	1	1	2
2004	1	1	2
2005	1	4	5
2006	1	3	4
2007	0	4	4
2008	1	2	3
2009	4	3	7
2010	1	2	3
2011	0	1	1
2012	1	3	4
2013	0	2	2
2014	1	3	4
2015	0	2	2
2016	0	3	3
2017	3	2	5
2019	1	2	3
2021	2	1	3
2023	0	3	3
2024	0	1	1
2025	0	1	1

Below are the most recent publications written about "Cholesterol, LDL" by people in Profiles.

Kim HJ, Kim YH, Yook HJ, Oh HJ, Min KH, Han KD, Park YG, Lee YB, Lee JH. Lower total cholesterol and HDL-C levels are associated with increased risk of Beh?et's disease in a prospective nationwide Korean study. Sci Rep. 2025 May 01; 15(1):15272.

View in: PubMed
Lee SY, Paul ME, Coleman AL, Kitayama K, Yu F, Pan D, Tseng VL. Associations between Statin Use and Glaucoma in the All of Us Research Program. Ophthalmol Glaucoma. 2024 Nov-Dec; 7(6):563-571.

View in: PubMed
Gandhi MM, Nguyen KL, Lake JE, Liao D, Khodabakhshian A, Guerrero M, Shufelt CL, Bairey Merz CN, Jordan WC, Daar ES, Bhattacharya D, Chew KW. Proprotein convertase subtisilin/kexin 9 levels decline with hepatitis C virus therapy in people with HIV/hepatitis C virus and correlate with inflammation. AIDS. 2024 03 01; 38(3):317-327.

View in: PubMed
Harzand A, Alrohaibani A, Idris MY, Spence H, Parrish CG, Rout PK, Nazar R, Davis-Watts ML, Wright PP, Vakili AA, Abdelhamid S, Vathsangam H, Adesanya A, Park LG, Whooley MA, Wenger NK, Zafari AM, Shah AJ. Effects of a patient-centered digital health intervention in patients referred to cardiac rehabilitation: the Smart HEART clinical trial. BMC Cardiovasc Disord. 2023 09 12; 23(1):453.

View in: PubMed
Oza PP, Kashfi K. The evolving landscape of PCSK9 inhibition in cancer. Eur J Pharmacol. 2023 Jun 15; 949:175721.

View in: PubMed
Patel KK, Kashfi K. Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs. Biochem Pharmacol. 2022 02; 196:114654.

View in: PubMed
Okoro EU. TNFa-Induced LDL Cholesterol Accumulation Involve Elevated LDLR Cell Surface Levels and SR-B1 Downregulation in Human Arterial Endothelial Cells. Int J Mol Sci. 2021 Jun 09; 22(12).

View in: PubMed
Matsumoto-Yamauchi H, Kondo K, Miura K, Tanaka-Mizuno S, Segawa H, Ohno S, Miyagawa N, Zaid M, Okami Y, Okuda N, Nakagawa H, Sakata K, Saitoh S, Okayama A, Yoshita K, Chan Q, Masaki K, Elliott P, Stamler J, Ueshima H. Relationships of Alcohol Consumption with Coronary Risk Factors and Macro- and Micro-Nutrient Intake in Japanese People: The INTERLIPID Study. J Nutr Sci Vitaminol (Tokyo). 2021; 67(1):28-38.

View in: PubMed
Torres E, Goicoechea M, Hern?ndez A, Rodr?guez Ferrero ML, Garc?a A, Mac?as N, Anaya F. Efficacy of Evolocumab vs low-density lipoprotein cholesterol apheresis in patients with familial hypercholesterolemia and high cardiovascular risk (EVOLAFER01). J Clin Apher. 2020 Jan; 35(1):9-17.

View in: PubMed
Roshandel G, Khoshnia M, Poustchi H, Hemming K, Kamangar F, Gharavi A, Ostovaneh MR, Nateghi A, Majed M, Navabakhsh B, Merat S, Pourshams A, Nalini M, Malekzadeh F, Sadeghi M, Mohammadifard N, Sarrafzadegan N, Naemi-Tabiei M, Fazel A, Brennan P, Etemadi A, Boffetta P, Thomas N, Marshall T, Cheng KK, Malekzadeh R. Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial. Lancet. 2019 08 24; 394(10199):672-683.

View in: PubMed

People

Explore

Similar Concepts

Top Journals